Effects of Targeting Lower Arterial Oxygen Saturations on the Development of Control of Breathing in Very Preterm Infants
- Conditions
- Development of Control of Breathing
- Interventions
- Other: Oxygen saturation range
- Registration Number
- NCT00573053
- Lead Sponsor
- University of Manitoba
- Brief Summary
To determine whether targeting lower arterial oxygen saturations from the day of birth alters the early (first 3 months) postnatal development of the control of ventilation and the hypercapnic and hyperoxic responses in very preterm infants.
- Detailed Description
To measure the effects of baseline oxygenation in extremely low birth weight preterm infants on:
i) The early (first 5 breaths) and late or steady state (3-5 minutes) ventilatory response to CO2 ii) The immediate (\< 1 minute) ventilatory response to hyperoxia iii) The PCO2 apneic threshold iv) The breathing pattern during quiet and REM sleep v) The morphology of periodic breathing cycles vi) The incidence and morphology of sighs
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 26
- Gestational age 23 0/7 - 27 6/7 weeks
- Enrolled in the COT trial at the Health Sciences Centre and the St. Boniface General Hospital in Winnipeg
- Postnatal age between 21 days and 70 days
- Informed written consent obtained from at least one of the parents.
- Need for mechanical ventilation, NCPAP or O2
- Sepsis or other known causes of apnea.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Low Oxygen saturation range Arterial oxygen saturations in the range of 85-89% High Oxygen saturation range Arterial oxygen saturations in the range of 91-95%
- Primary Outcome Measures
Name Time Method Effects of targeting lower arterial oxygen saturations on the development of control of breathing in very preterm infants 3 months
- Secondary Outcome Measures
Name Time Method To measure the effects of baseline oxygenation in extremely low birth weight preterm infants on the ventilatory response to CO2 and O2, the PCO2 apneic threshold, and the baseline breathing pattern 3 months
Trial Locations
- Locations (2)
St. Boniface General Hospital
🇨🇦Winnipeg, Manitoba, Canada
Health Science Centre
🇨🇦Winnipeg, Manitoba, Canada